Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI
RESEARCH TOOLSreports
Intra-Cellular Therapies (ITCI) Financial Statements
853 Followers
Intra-Cellular Therapies Financial Overview
| Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 144.84M | $ 133.13M | $ 126.17M | $ 110.13M | $ 95.31M |
| Gross Profit | $ 134.94M | $ 113.48M | $ 126.17M | $ 110.79M | $ 95.31M |
| EBIT | $ -20.95M | - | $ -24.21M | $ -42.65M | $ -44.04M |
| EBITDA | $ -20.82M | - | $ -26.27M | $ -44.46M | $ -45.65M |
| Net Income Common Stockholders | $ -15.25M | $ -28.58M | $ -6.00M | $ -42.78M | $ -44.05M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 475.62M | $ 497.94M | $ 493.02M | $ 514.60M | $ 540.46M |
| Total Assets | $ 747.04M | $ 728.29M | $ 717.66M | $ 713.60M | $ 720.38M |
| Total Debt | $ 16.38M | $ 16.94M | $ 17.48M | $ 17.99M | $ 18.49M |
| Net Debt | $ -459.25M | $ -481.00M | $ -475.55M | $ -496.61M | $ -521.97M |
| Total Liabilities | $ 147.54M | $ 136.87M | $ 116.98M | $ 106.51M | $ 94.55M |
| Stockholders Equity | $ 599.50M | $ 591.42M | $ 600.68M | $ 607.09M | $ 627.61M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -34.12M | - | $ -25.54M | $ -36.80M | $ -60.07M |
| Operating Cash Flow | $ -34.12M | $ -2.06M | $ -25.27M | $ -36.80M | $ -60.07M |
| Investing Cash Flow | $ 16.18M | $ 47.42M | $ -20.17M | $ 94.75M | $ -16.46M |
| Financing Cash Flow | $ 9.99M | $ 3.00M | $ 2.58M | $ 8.59M | $ 3.64M |